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Disseminated intravascular coagulation (DIC) can be 
defined as evidence of activation of the coagulation mecha-
nism resulting in proteolysis of fibrinogen by thrombin and 
plasmin and an acute thrombocytopenia. 
The association of pulmonary embolism (PE) with DIC has 
recently been reported but in reviewing recent textbooks of 
hematology, there is no mention of PEas a cause of DJC1.7. 
Clinicians need to be made aware of this association since 
it affects the patient who is thought to be autoanticoagulated 
as well as the patient who has DIC of unknown cause. PE 
needs to be included in the differential diagnosis of an autoan-
ticoagulated state and in DIC of unknown etiology. In both 
instances the recommended treatment is full-dose intravenous 
heparin therapi·v. 
Pulmonary embolism accounts for an estimated 300,000 
hospitalizations and as many as 50,000 deaths annually6• 
Despite advances in diagnostic imaging it may go undetected 
until postmortem examination. Recognition of the association 
between DIC and pulmonary embolism may enhance the 
accuracy of the clinical diagnosis. 
We report 2 cases of an unusual presentation of a massive 
PEandDIC. 
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Case reports 
Case 1 
A 47-year-old Japanese man complained of a sudden onset 
of shortness of breath, hemoptysis and near loss of conscious-
ness. Twelve days earlier he had undergone coronary artery 
bypass grafting. 
He was known to have had diabetes mellitus and hyperten-
sion. Physical examination revealed left lung-field crackles. 
The admission chest roentgenogram demonstrated a small left 
pleural effusion. Laboratory tests were remarkable for throm-
bocytopenia. On arterial blood gas analysis, he had a widened 
A-a gradient. 
A pulmonary angiogram demonstrated multiple bilateral 
pulmonary emboli. The patient subsequently developed bleed-
ing into the thigh, thrombocytopenia, and other coagulation 
abnormalities. Fibrin split products (FSP) were increased, 
resulting in a decrease of the fibrinogen level. A bone-marrow 
aspiration was read as normal. A diagnosis of DIC was made. 
The patient recovered after treatment with full heparinization. 
Case2 
An 80-year-old Caucasian woman with a history of steroid-
dependent chronic obstructive pulmonary disease was admit-
ted to hospital for treatment of Pseudomonas pneumonia. 
CBC and platelets were normal at admission. 
Her medical history was also notable for congestive heart 
failure. Physical examination revealed dyspnea without 
cyanosis. The patient had a prolonged hospital course due to 
persistent weakness and shortness of breath. Primary hyper-
thyroidism was then diagnosed. An acute anemia developed. 
FSP were increased and the fibrinogen level was decreased. 
Acute thrombocytopenia developed and DIC was diagnosed. 
Heparin was not instituted given the presence of hematologic 
abnormalities. The patient died and at autopsy a massive, sad-
dle, pulmonary embolus was found completely occluding both 
right and left lungs. 
Discussion 
Case 1 clinically illustrates DIC associated with a pul-
monary embolus. Specifically, there was an acute thrombocy-
topenia and evidence of activation of the coagulation mecha-
nism resulting in proteolysis of fibrinogen by thrombin and 
plasmin. This is the definition ofDIC7 • 
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The biochemical abnormalities can be detected by testing 
for circulating fibrin monomers and fibrin-degradation prod-
ucts. Once the occurrence of PE and DIC was recognized, 
treatment with heparin corrected the hematologic abnormali-
ties and allowed the patient to recover. 
Case 2 serves as a reminder that even in those clinical set-
tings in which DIC can occur, PE may be present and should 
be considered even if laboratory examination suggests autoan-
ticoagulation. The presence of an autoanticoagulation picture 
should not deter the clinician from treating with full doses of 
heparin, since the autoanticoagulation may represent DIC sec-
ondary to PE1•5•6• 
This association between PE and DIC is not well known 1•7• 
The proposed mechanisms by which PE may result in DIC 
include: Liberation of tissue factors , endothelial damage, vas-
cular malformation, decreased blood flow7 • 
Stahl studied this association in 6 patients with DIC of 
unknown etiology and in each case he was able to document, 
by pulmonary angiogram or scanning, coexisting PE. Included 
were patients with DIC and DVT, DIC after aortic valve 
replacement, DIC after uncomplicated hemicolectomy for a 
benign villous adenoma, DIC and ulcerative colitis, DIC post-
abdominal aortic surgery and DIC after a cesarean section. All 
cases were found to have coagulation abnormalites and evi-
dence of DIC with thrombocytopenia. Full-dose heparin treat-
ment resolved their hematologic abnormalities as well as their 
pulmonary emboli1• 
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PE associated with an elevation of FSP was first described 
by Merskey. Elevated FSP was thought to represent the defib-
rination syndrome wherein fibrinolysis was the result of 
degradation and resolution of emboli2• Recent evidence sug-
gests that PE itself activates the coagulation mechanism 
resulting in increased FSP and decreased fibrinogen levels; 
this activation is not expected to occur from fibrinolysis of an 
embolus. 
Support for this concept comes from the finding that the 
fibrin formed after embolization has occurred is different from 
the fibrin in the original embolus itself. A study in dogs in 
which an I -125 fibrin-labeled autologous clot was embolized 
into the dog lung, revealed that the subsequent appearance of 
fibrin degradation products did not contain the radioactive 
label. Heparin given just prior to embolization was able to 
markedly inhibit the consumption of fibrinogen and the pro-
duction of degradation products8• This suggests further evi-
dence that DIC occurred secondary to PE; rather than fibrinol-
ysis of the embolus. 
This appears to be a specific activation that occurs in the 
lung; patients with thrombophlebitis or deep venous thrombo-
sis give no evidence of DIC or of an increase in FSP unless 
there is also a P£3-8• In a study of 46 patients with suspected 
PE, the concentration of FSP when compared with the angio-
graphic findings revealed that FSP was increased above 10 
micrograms per milliliter in 19 patients with angiographically 
documented PE and were not elevated at all in the 22 patients 
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that were negative for PE. There were 5 patients with equivo-
cal findings•. 
Conclusion 
Pulmonary embolism should be included in the differential 
diagnosis of DIC of unknown origin because prompt treat-
ment with full-dose heparin will correct the hematologic 
abnormalities as well and may be lifesaving. An autoanticoag-
ulated state does not always prevent the formation of thrombi, 
and it may obscure an occult PE. The presence of FSP may 
add to the understanding of the pathophysiology in PE and 
may be a laboratory clue that can assist in the management of 
both PE and DIC. This occurrence merits wider recognition 
by clinicians and further studies need to be conducted. 
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